<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="IR (immediate-release) has been modified to ER (extended-release) for the" exact="treatment" post="of epilepsy. Valproate ER has driven numerous promising outcomes"/>
 <result pre="developers to fulfil demands, especially for diseases that lack drug" exact="treatment" post="or are otherwise expensive to treat. Of course, profit"/>
 <result pre="Chloroquine (CQ) and its derivates for consideration as a potential" exact="treatment" post="for COVID-19 [14]. There are many advantages to adopting"/>
 <result pre="role in tackling epidemics and pandemics where little or no" exact="treatment" post="is available, for orphan diseases and personalised medicine. Also,"/>
 <result pre="drugâ€&quot;disease comparison investigates the gene expression profiles before and after" exact="treatment" post="with the potential drug. Subsequently, result comparisons are made"/>
 <result pre="cells when screened across the drug-associated gene expression database. The" exact="screening" post="result implied that Rapamycin might be a promising treatment"/>
 <result pre="The screening result implied that Rapamycin might be a promising" exact="treatment" post="for lymphoid malignancies [18]. On the other hand, the"/>
 <result pre="is advised to perform more than one computational approach when" exact="screening" post="for drug targets rather than relying on molecular docking"/>
 <result pre="database, few potential drug repositioning candidates are discovered for the" exact="treatment" post="of respiratory viral infection. One of them is the"/>
 <result pre="drug Amrinone, a phosphodiesterase inhibitor that was used for the" exact="treatment" post="of congestive heart failure [26]. Also, multiple omics analysis"/>
 <result pre="omics analysis mapped to significant pathways allows for the simultaneous" exact="detection" post="of target genes and human proteins for their potential"/>
 <result pre="a few limitations. As such, the difficulty in training and" exact="screening" post="a large number of compounds accompanied by the improvement"/>
 <result pre="in the search of potential drug repositioning candidates for the" exact="treatment" post="of COVID-19 [39]. The study has shown a vital"/>
 <result pre="once daily, to inhibit the AAK1, contributing to an effective" exact="treatment" post="with low unpleasant side-effects [39,40]. In sum, the computational"/>
 <result pre="treat hair loss aside from its intended use for the" exact="treatment" post="of hypertension. The success of drug repositioning continued in"/>
 <result pre="drug that was intended to treat hypertension then became a" exact="treatment" post="for hair loss prevention [49,50]. Minoxidil was first introduced"/>
 <result pre="1979 as a topical application for hair loss (androgenic alopecia)" exact="treatment" post="[13,52,53]. Its mechanism functioned by causing vasodilation via the"/>
 <result pre="coronary blood flow. However, it opened up possibilities for the" exact="treatment" post="of erectile dysfunction when several volunteers experienced a strong,"/>
 <result pre="widely available over the counter. It works primarily as a" exact="treatment" post="for erectile dysfunction via the same mode of action"/>
 <result pre="small population, typically less than 200,000, in which no effective" exact="treatment" post="is available [59,60,61]. This phenomenon is primarily due to"/>
 <result pre="diseases, pulling the gap closer between the availability of drug" exact="treatment" post="to diseases within a population. To speed things up,"/>
 <result pre="associated with many non-cancerous tumours, known as hamartomas [70]. The" exact="prevalence" post="of this genetic disorder is 1 in 6000 new-borns,"/>
 <result pre="the 1960s to prevent solid organ transplant rejection, augment anticancer" exact="treatment" post="regimens and to prevent neovascularisation of artificial cardiac stents."/>
 <result pre="opened many possibilities on disease treatment, pulling the gap of" exact="treatment" post="and diseases closer one-step to eradication. Also, it increases"/>
 <result pre="been successfully repositioned to be an antiretroviral drug for HIV" exact="treatment" post="today [75,76]. It is grouped under the NRTIs and"/>
 <result pre="iodixanol, and sirolimus work synergistically at specific concentrations for HIV" exact="treatment" post="via molecular docking simulations [78]. 5.2. New Life to"/>
 <result pre="metronidazole-resistant Giardia Lamblia, which accommodated up to 20% of the" exact="treatment" post="failure cases [68]. Giardiasis is an uncommon disease that"/>
 <result pre="as a more effective strategy for the search of a" exact="treatment" post="for COVID-19 as it suits the urgency for the"/>
 <result pre="COVID-19 as it suits the urgency for the need of" exact="treatment" post="[83]. COVID-19 is caused by severe acute respiratory syndrome"/>
 <result pre="been suggested as potential drugs to be used in the" exact="treatment" post="of COVID-19 patients in the time before a specific"/>
 <result pre="drug against COVID-19 [88]. Other drugs in consideration for COVID-19" exact="treatment" post="include Favipiravir and Ivermectin. Favipiravir, which was originally developed"/>
 <result pre="in vitro study, Caly et al. reported that a single" exact="treatment" post="of Ivermectin expressed a significant reduction in SARS-CoV-2 viral"/>
 <result pre="already available therapeutic targets that can be repurposed for SARS-CoV-2" exact="treatment" post="via systematically analysing the proteins encoded by SARS-CoV-2 genes"/>
 <result pre="inhibitors of RbRp and may result in the reduction of" exact="infection" post="severity. Multiple software were used to validate the RdRp"/>
 <result pre="or its alternatives CQ phosphate or Hydroxychloroquine (HCQ) for the" exact="treatment" post="of SARS-CoV-2 patients. Initially, CQ and HCQ were considered"/>
 <result pre="always required. CQ has been reported previously to block virus" exact="infection" post="in a few ways such as through increasing the"/>
 <result pre="drugs, ribavirin, and CQ showed excellent potential in blocking virus" exact="infection" post="at low drug micromolar concentrations. Another study recommends the"/>
 <result pre="study recommends the usage of CQ phosphate as the potential" exact="treatment" post="of COVID-19 in this time as it has exhibited"/>
 <result pre="sulphate has been studied for its antiviral effect on SARS-CoV-2" exact="infection" post="and has been compared with CQ alone for cytotoxicity"/>
 <result pre="successfully shown that HCQ sulphate is effective in inhibiting SARS-CoV-2" exact="infection" post="and may be a better option for consideration in"/>
 <result pre="levels possible to the specific individual in contrast to conventional" exact="treatment" post="that aims for maximum tolerated doses. For instance, non-small"/>
 <result pre="treat this small subset of NSCLC [81]. Without the advance" exact="screening" post="of biomarkers in each NSCLC individual, this small subset"/>
 <result pre="drug Crizotinib (Pfizerâ€™s Xalkori) successfully obtained FDA approval as a" exact="treatment" post="for patients with NSCLC with MET exon 14 skipping"/>
 <result pre="glucocorticoid Prednisolone acetate and the immunosuppressant Cyclosporine A for the" exact="treatment" post="of allergic conjunctivitis [63]. Apart from this, the lack"/>
 <result pre="and a new life for old drugs. New high throughput" exact="screening" post="techniques coupled with advanced computational methods such as signature"/>
 <result pre="computational drug repositioningBrief. Bioinform.20111230331110.1093/bib/bbr01321690101 14.GautretP.LagierJ.ParolaP.HoangV.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraV.et al.Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: Results of an open-label non-randomised clinical trialInt."/>
 <result pre="Model.20155526327410.1021/ci500747n25635324 37.SpauldingA.RutherfordG.SiegfriedN.Stavudine or Zidovudine in three-drug combination therapy for initial" exact="treatment" post="of HIV infection in antiretroviral-naÃ¯ve individualsCochrane Database Syst. Rev.201010.1002/14651858.CD008651"/>
 <result pre="Zidovudine in three-drug combination therapy for initial treatment of HIV" exact="infection" post="in antiretroviral-naÃ¯ve individualsCochrane Database Syst. Rev.201010.1002/14651858.CD008651 38.WenM.ZhangZ.NiuS.ShaH.YangR.YunY.LuH.Deep-Learning-Based Drugâ€&quot;Target Interaction"/>
 <result pre="Rev.201010.1002/14651858.CD008651 38.WenM.ZhangZ.NiuS.ShaH.YangR.YunY.LuH.Deep-Learning-Based Drugâ€&quot;Target Interaction PredictionJ. Proteome Res.2017161401140910.1021/acs.jproteome.6b0061828264154 39.RichardsonP.GriffinI.TuckerC.SmithD.OechsleO.PhelanA.StebbingJ.Baricitinib as potential" exact="treatment" post="for 2019-nCoV acute respiratory diseaseLancet2020395e30e3110.1016/S0140-6736(20)30304-432032529 40.VelavanT.MeyerC.The COVID-19 epidemicTrop. Med."/>
 <result pre="63.XuK.CoteT.Database identifies FDA-approved drugs with potential to be repurposed for" exact="treatment" post="of orphan diseasesBrief. Bioinform.20111234134510.1093/bib/bbr00621357612 64.SunW.SandersonP.ZhengW.Drug combination therapy increases successful"/>
 <result pre="of the EXIST-2 studyPLoS ONE201712e018093910.1371/journal.pone.018093928792952 72.FranzD.CapalJ.Profile of Everolimus in the" exact="treatment" post="of tuberous sclerosis complex: An evidence-based review of its"/>
 <result pre="of a novel SARS-CoV-2Gene Rep.2020191710.1016/j.genrep.2020.100682 85.WangH.LiX.LiT.ZhangS.WangL.WuX.LiuJ.The genetic sequence, origin, and" exact="diagnosis" post="of SARS-CoV-2Eur. J. Clin. Microbiol. Infect. Dis.202011710.1007/s10096-020-03899-4 86.TimesN.S.Thailand Sees"/>
 <result pre="less toxic derivative of Chloroquine, is effective in inhibiting SARS-CoV-2" exact="infection" post="In VitroCell Discov.2020610.1038/s41421-020-0156-032194981 88.HarrisonC.Coronavirus puts drug repurposing on the"/>
 <result pre="Sci. USA199693118651187010.1073/pnas.93.21.118658876229 98.VincentM.BergeronE.BenjannetS.EricksonB.RollinP.KsiazekT.SeidahN.NicholS.Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol. J.200526910.1186/1743-422X-2-6916115318 99.HelalG.GadM.Abd-EllahM.EidM.Hydroxychloroquine augments early virological response to"/>
 <result pre="for 2019-nCoV InfectionClin. Pharmacol. Ther.202010.1002/cpt.1844 104.MomekovG.MomekovaD.Ivermectin as a potential COVID-19" exact="treatment" post="from the pharmacokinetic point of viewmedRxiv202010.1101/2020.04.11.20061804 105.AmirianE.LevyJ.Current knowledge about"/>
 <result pre="(SUI) [5] Everolimus Prevent solid organ transplant rejection, Augment anticancer" exact="treatment" post="regimens, Prevent neovascularisation of artificial cardiac stents Tuberous sclerosis"/>
 <result pre="vision Cold sores Shingles Possible increase in upper respiratory tract" exact="infection" post="Hypercholesterolemia Hypertension Urinary tract infection A high-affinity NAK inhibitor,"/>
 <result pre="increase in upper respiratory tract infection Hypercholesterolemia Hypertension Urinary tract" exact="infection" post="A high-affinity NAK inhibitor, especially on AP2-associated protein kinase"/>
</results>
